Funding · Company
ONL Therapeutics, Inc.
Ann Arbor, MIBiotech & Pharma
ONL Therapeutics, Inc. of Ann Arbor, MI has disclosed $60M across 1 Form D offering filed with the SEC on Sep 16, 2024.
$60M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$60M
Form D · Sep 16, 2024 ↗
Q3 2024
· target $65M
Filing details
HeadquartersAnn Arbor, MIIndustryBiotech & Pharma (Biotechnology)SEC CIK0001611793Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →